Table 3.

Demographic and clinical details of group ‘A’ hosts.

Patient Number	Age (at Admission)	Sex	Bone Affected	Length of Admission	Causative Organism	IV Antibiotic Prescribed	Recurrence
1	35	M	Tibia	3	Staph aureus	Tazocin IV	No
2	57	M	Tibia	1	Coagulase Negative Staph	Vancomycin IV	No
3	53	F	Fibula	26	MRSA	Vancomycin IV	No
4	28	M	Clavicle	2	Coagulase Negative Staph	Tazocin IV	No
5	35	M	Femur	25	Staph aureus	Gentamicin IV	No
6	55	M	Tibia	8	No Growth	Vancomycin IV	No
7	68	M	Fibula	4	P. aeruginosa	Pipercillin IV	No
8	30	M	Femur	3	P. aeruginosa	Tazocin IV	No
9	18	F	Femur	1	E. coli	Tazocin IV	No
10	30	M	Tibia	5	Salmonella	Data not available	No
11	25	M	Humerus	6	Staph aureus	Vancomycin IV	No
12	20	M	Femur	1	Staph aureus	Oral antibiotics only	No
13	27	F	Femur	8	Staph aureus	Data not available	No
14	48	F	Femur	3	No Growth	Flucloxacillin IV	No
15	36	M	Radius	2	Coagulase Negative Staph	Data not available	No
16	38	F	Femur	14	P. aeruginosa	Gentamicin IV	No
17	15	F	Tibia	12	Coagulase Negative Staph	Vancomycin IV	No
18	65	M	Tibia	7	Corynebacterium striatum	Vancomycin IV	Yes
19	40	M	Tibia	3	E. coli	Vancomycin IV	Yes
20	40	F	Ulna	9	Staph aureus	Vancomycin IV	No
21	25	M	Tibia	14	Streptococcus pyogenes Group A	Ertapenum IV	Yes
22	56	M	Tibia	4	Staph aureus	Metronidazole IV	No
23	26	M	Radius	3	Staph aureus	Vancomycin IV	No
24	38	M	Femur	7	Coagulase Negative Staph	Vancomycin IV	No
	Mean = 37.8	Male = 71%		Mean = 7.1			Total recurrences = 3
	SD = 14.8	Female = 29%		SD = 6.8